We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORK:EURONEXT OSLOOrkla ASA Analysis

Data as of 2026-05-30 - not real-time

$1.16

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Orangekloud Technology Inc. shows impressive top‑line momentum, with revenue climbing 60.9% year‑over‑year to roughly $5.7 million, yet the company is still deep in the red – operating margin sits at –112.8% and free cash flow is –$1.77 million. The balance sheet is thin, with total cash of $2.99 million offset by $1.57 million of debt, yielding a debt‑to‑equity ratio of 18.5, and the firm’s ROE and ROA are both negative. On the valuation side, the stock trades at a price‑to‑sales multiple of 1.19 and a price‑to‑book of 1.02, which is modest compared with the industry’s average PE of 41.86, but earnings are negative so traditional PE metrics are not meaningful. Technical indicators suggest a short‑term bullish bias: the price of $1.16 sits just below the near‑term resistance of $1.19, the 20‑day SMA (1.045) and 50‑day SMA (1.036) are both under the current price, the MACD histogram is positive, and the RSI at 67.7 hints at mild overbought pressure. However, volatility is extreme at 68% over the last 30 days and the stock has experienced a historic drawdown of nearly 80%. The beta of 0.74 indicates lower systematic risk than the market, but the small market cap (~$6.8 million) and stable yet modest volume raise liquidity concerns. Overall, the combination of rapid revenue growth, ongoing cash burn, and a fragile balance sheet makes the stock a high‑risk play despite its relatively cheap valuation ratios.
Given the “Extreme Greed” sentiment in the fear‑and‑greed index, speculative interest may be driving price, but without a clear path to profitability the upside is limited. Investors should weigh the growth potential of the no‑code platform against the company’s inability to generate positive earnings and cash flow, and consider the high volatility and liquidity constraints before taking a position.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near resistance with bullish MACD
  • High short‑term volatility
  • Negative cash flow but strong revenue growth

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued operating losses and cash burn
  • Uncertain path to profitability
  • Liquidity constraints in a small‑cap stock

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Sustained negative earnings and ROE
  • High historical drawdown risk
  • Lack of dividend and limited financial runway

Key Metrics & Analysis

Financial Health

Revenue Growth60.90%
Profit Margin-78.68%
P/E Ratio-1.2
ROE-40.52%
ROA-33.50%
Debt/Equity18.48
P/B Ratio1.0
Op. Cash Flow$-4566961
Free Cash Flow$-1773653
Industry P/E41.9

Technical Analysis

TrendNeutral
RSI67.7
Support$0.84
Resistance$1.19
MA 20$1.04
MA 50$1.04
MA 200$1.39
MACDBullish
VolumeStable
Fear & Greed Index94.07

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta0.74
Volatility67.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.